ARDS

Category

At-Home Decentralized COLCORONA Trial Investigates if Colchicine Keeps COVID-19 Symptoms from Progressing to Reduce Hospitalization & Death

There is presently no available, FDA-approved medicine that can be administered at a patient’s home that can prevent the negative progression of SARS-CoV-2 symptoms leading to hospitalization and potentially death. Can a widely available, generic drug used for gout...

Canada Health Greenlights Clinical Trial Investigating NuvOx’s Oxygen Therapeutic as a Treatment for COVID-19-based AHRF

NuvOX Pharma, a Tucson Arizona-based biotechnology company, received the green light in the form of a “No Objection Letter” form Health Canada to initiate a Phase 2a clinical trial investigating NanO2 in COVID-19 patients with acute hypoxic respiratory failure (AHRF)....

Landmark Hospitals Compassionate Use Study for Critical COVID-19 Patients Evidences Potential for Allogenic Biologic Product

Landmark Hospital manages six long-term acute care hospitals across the Southeast United States and recently announced its decision to offer an investigational allogenic biologic product derived from amniotic fluid to patients with advanced COVID-19 conditions under...

HHMI-backed Johns Hopkins Hosted Team Investigates Use of Alpha Blockers (Prazosin) to Combat a Deadly COVID-19 Condition: Cytokine Storm

Although considered eccentric toward the end, Howard Hughes was incredibly rich and put that capital to work in many interesting and important ways, including what has become one of the largest private funding organizations for biological medical research in the...

UCI Investigates Synthetic Vasoactive Intestinal Polypeptide-based Experimental Drug on High Risk SARS-CoV-2 Patients

University of California Irvine, (UCI) recently announced their participation in a COVID-19-focused clinical trial investigating a drug called Aviptadil in at risk patients. Dr. Richard Lee, Interim chief of UCK Health Division of Pulmonary Diseases and Critical Care...

Pin It on Pinterest